Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy (Q38033459)

27 August 2017

Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy (English)

1 reference

27 August 2017

neoplastic stem cells

1 reference

1 reference

Sonshin Takao

1

1 reference

27 August 2017

Qiang Ding

series ordinal

2

1 reference

27 August 2017

Shyuichiro Matsubara

series ordinal

3

1 reference

27 August 2017

1 November 2012

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

27 August 2017

1 reference

27 August 2017

19

1 reference

27 August 2017

6

1 reference

27 August 2017

614-620

1 reference

https://scigraph.springernature.com/pub.10.1007/s00534-012-0547-1

27 August 2017

0 references

cites work

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

HIF induces human embryonic stem cell markers in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Interactions between cancer stem cells and their niche govern metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

A perspective on cancer cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Epithelial-mesenchymal transition and the invasive potential of tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Deregulation of FoxM1b leads to tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

CD44v6 dependence of premetastatic niche preparation by exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

A paracrine requirement for hedgehog signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

MicroRNA alterations of pancreatic intraepithelial neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0547-1

10.1007/S00534-012-0547-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference